278
Views
40
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, DNA-binding, cytotoxicity, and cleavage studies of unsymmetrical oxovanadium complexes

, , , , , , & show all
Pages 191-204 | Received 05 Sep 2011, Accepted 11 Nov 2011, Published online: 21 Dec 2011
 

Abstract

An unsymmetrical oxovanadium complex [VO(SAA)(phen)] (1) (SAA = salicylidene anthranilic acid, phen = phenanthroline) and its derivative [VO(MOSAA)(phen)] (2) (MOSAA = 2-hydroxy-4-methoxysalicylidene anthranilic) have been synthesized and characterized by elemental analysis, UV-Vis, ES-MS, IR, and 1H NMR. The interaction of these two complexes with calf thymus DNA (CT-DNA) was investigated by absorption titration, fluorescence spectra, viscosity measurements, and thermal denaturation. Their photocleavage reactions with pBR322 supercoiled plasmid DNA were investigated by gel electrophoresis. The cytotoxicity of these two complexes against myeloma cell (Ag8.653) and gliomas cell (U251) have been assessed by MTT assay. The results show that both 1 and 2 bind to CT-DNA in classical intercalation, and the DNA-binding affinity of 1 is larger than that of 2. These complexes enhance the oxidative cleavage of supercoiled pBR322 DNA and both complexes have cytotoxic activities against Ag8.653 and U251 cell lines. Complex 1 has more potent inhibitory effect against the two cell lines than 2.

Acknowledgments

We gratefully acknowledge financial support for this work by Guangdong Pharmaceutical University (No. 43540119), the National Key Research Project of China (No. 2011zx09102-001-31), and the National Natural Science Foundation of P.R. China (Nos 81102753 and 31070858).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.